中/EN
中文繁體
English
Investor Relations
IR Home
Corporate Overview
Financial Highlights
Financial Reports
ESG Reports
Regulatory Filings
Press Releases
Company Presentations
Stock Quotes & Charts
Analyst Coverage
FAQs
IR Contact
Corporate
Investor Relations
IR Home
Corporate Overview
Financial Highlights
Financial Reports
ESG Reports
Regulatory Filings
Press Releases
Company
Presentations
Stock Quotes &
Charts
Analyst Coverage
FAQs
IR Contact
Press Releases
2012
Please select
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
AUG
23
The United Laboratories International Holdings Limited Announces 2012 Interim Results, Turnover Increased to HK$3.65 Billion Prices of Intermediate Products and Bulk Medicine Becomes Stable Overseas Sales Surges 35.7%
JUN
12
Media Reports of TUL Pollution in Wuliangsuhai Fabricated
APR
18
TUL's Capsule Casings in Full Compliance with National Safety Standards
MAR
28
The United Laboratories International Holdings Limited Announces 2011 Annual Results, Achieved Turnover of Approximately HK$6.4 Billion, Prices of Intermediate Products and Bulk Medicine Becomes Stable in 2012, Orders of Human Insulin Increases Gradually